Archives
-
o2h Ventures recognized as a finalist for the EISA Impact Award for 2023 08 June, 2023
-
PharmEnable raises $7.5M in Pre-Series A funding round with a follow-on investment from o2h Ventures 29 May, 2023
-
Is Investing in SEIS ventures risky? – Join the o2h Chaitime Webinar 10 May, 2023
-
Tay Therapeutics, an o2h Ventures portfolio company secures a licensing deal worth over $65 million 05 May, 2023
-
o2h Ventures deals pipeline, Knowledge-intensive EIS Fund closing on 5th April 2023 01 March, 2023
-
Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events 01 November, 2022
-
Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates 30 September, 2022
-
July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio 01 August, 2022
-
May 2022, o2h Ventures Fund Newsletter, SEIS fund close deadline June 30th 2022 28 May, 2022
invest in the growth potential of UK life science & AI